-
Document de presse | 2014.10.13
Human papillomavirus linked to auto-immune disease
Erosive oral lichen planus (OLP) is an auto-immune disease affecting skin and mucous membranes which results in an abnormal immune response against mucocutaneous cells. Today, scientists at the Institut Pasteur, Inserm, Paul Sabatier University (Toulouse) and the CNRS have proven that the immune cells involved in OLP are the same as those activated during an immune response to human...
-
Document de presse | 2010.12.01
Identification of the 3D structure of chikungunya virus surface proteins
Researchers at the Institut Pasteur and CNRS, in collaboration with the Synchrotron SOLEIL, have solved the three-dimensional atomic structure of the glycoproteins that envelop the chikungunya virus. This discovery helps to understand how this protein complex is activated in order for the virus to invade target cells. Activation is a key stage in the viral life cycle and understanding its...
-
Document de presse | 2009.05.17
The Institut Pasteur and Mérieux Alliance take First Step Towards a Long-term Research Partnership in the Field of Infectious Diseases
The Institut Pasteur and Mérieux Alliance have signed a letter of intent for a long-term research partnership. Communiqué de presse Paris, lmay 18, 2010 The Institut Pasteur and Mérieux Alliance (which comprises the companies: bioMérieux, Transgene, Shantha Biotechnics, ABL and Silliker) would like to pool their resources and efforts to fight infectious diseases...
-
Document de presse | 2008.02.14
Chikungunya: an animal model, at last !
Researchers from the Institut Pasteur and INSERM have developed the first mouse model for chikungunya virus infection. This animal model mimics both the benign and severe forms of the disease. As a result, the scientists have determined which tissues and cells are infected by the virus in each of these clinical conditions. The development of such an animal model is a major advance, not only at...
-
Fiche maladie | 2023.11.27
Dengue
Dengue, also known as ‘tropical flu’, is an infectious disease caused by the virus of the same name. The virus is transmitted by mosquitoes of the genus Aedes. The incidence of dengue is rising rapidly and it is currently considered a ‘re-emerging’ disease.
-
Article | 2017.11.10
Nicolle Class (2017-2020)
Ph.D. StudentUndergraduate studiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. project Diana Paola BAQUERO URIZA Universidad de los Andes, Bogotá, Colombia Molecular Biology of the Gene in ExtremophilesPrangishvili David & Krupovic Mart (as co-advisor)Forterre Patrick CdVMolecular mechanisms of virus release in ArchaeaPaulo BASTOS University of Aveiro,...
-
Article | 2017.11.10
Nicolle Class (2017-2020)
Ph.D. StudentUndergraduate studiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. project Diana Paola BAQUERO URIZA Universidad de los Andes, Bogotá, Colombia Molecular Biology of the Gene in ExtremophilesPrangishvili David & Krupovic Mart (as co-advisor)Forterre Patrick CdVMolecular mechanisms of virus release in ArchaeaPaulo BASTOS University of Aveiro,...
-
News | 2018.09.26
2016 yellow fever outbreak in Brazil: tiger mosquitoes are also capable of transmitting the virus
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo. These two states, the most heavily populated in Brazil, had been free of yellow fever for nearly 70 years. Research by scientists at the...
-
Document de presse | 2019.07.11
High-risk pregnancy: the interferon effect
Discovery of a cellular mechanism involved in abnormal placental development during some high-risk pregnancies.High-risk pregnancies occur frequently and may be caused by various factors. It is estimated that 10 to 20% of pregnant women miscarry during their first trimester of pregnancy. Slow fetal growth may also arise as a result of maternal infection with certain microbes, parasites or viruses...
-
Document de presse | 2020.05.26
COVID-19: the vast majority of patients with a minor form develop neutralizing antibodies
Teams from Strasbourg University Hospital and the Institut Pasteur carried out a study among hospital staff on the two sites of Strasbourg University Hospital. After observing 160 people with minor forms of COVID-19, the scientists concluded that nearly all the patients developed antibodies within two weeks of being infected. In 98% of the patients, neutralizing antibodies were detected after 28...